Schedule 13D ownership disclosure

Tango Therapeutics Inc

Security class unavailable · CUSIP: 87583X109

Event date: 2024-08-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-213369
Form type
SC 13D/A
Filer
Tango Therapeutics, Inc.
CIK
CIK 1819133
Filed
Sep 04, 2024
Reporting period
Aug 30, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub